News, musings and commentary on dietary supplements & pharmaceutical law issues, technology, and litigation.
Lawyers for consumers and injured people.(No advice on this blog, though)
mark(at)markzamora.com
Monday, March 15, 2010
Boston Scientific: Medical device maker suspends sale of two product
Boston Scientific Corp. discovered a documentation error in its regulatory filings “in the last few days” that led the company to halt sales of its cardiac defibrillators.
The two devices that the Natick, Mass.-based company have temporarily shelved are its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators